Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ONC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Titus B. Ball Principal Accounting Officer | ONC BeOne Medicines Ltd. | Sale | 26 | $406.34 | $10.6K Sale | Form 4 ↗ |
| Nov 6, 2026 | Titus B. Ball Principal Accounting Officer | ONC BeOne Medicines Ltd. | Sale | 1,533 | $405.55 | $621.7K Sale | Form 4 ↗ |
| Nov 5, 2026 | Chan Henry Lee SVP, General Counsel | ONC BeOne Medicines Ltd. | Sale | 455 | $402.00 | $182.9K Sale | Form 4 ↗ |
| Nov 5, 2026 | Chan Henry Lee SVP, General Counsel | ONC BeOne Medicines Ltd. | Sale | 660 | $400.00 | $264.0K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 6,903 | $366.22 | $2.5M Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 3,965 | $365.43 | $1.4M Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 2,841 | $363.95 | $1.0M Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 8,148 | $363.24 | $3.0M Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 2,331 | $362.35 | $844.6K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 320 | $360.64 | $115.4K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,280 | $359.72 | $460.4K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,681 | $358.75 | $603.1K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,239 | $357.54 | $443.0K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,440 | $355.62 | $512.1K Sale | Form 4 ↗ |
| Oct 27, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 880 | $355.56 | $312.9K Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 738 | $367.23 | $271.0K Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 14,525 | $366.58 | $5.3M Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 2,047 | $365.85 | $748.9K Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 3,419 | $364.07 | $1.2M Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 3,499 | $363.10 | $1.3M Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 4,239 | $362.17 | $1.5M Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 2,241 | $361.05 | $809.1K Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 40 | $359.16 | $14.4K Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 120 | $358.71 | $43.0K Sale | Form 4 ↗ |
| Sep 28, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 160 | $356.97 | $57.1K Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 6,278 | $351.25 | $2.2M Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 6,569 | $350.27 | $2.3M Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 10,688 | $349.28 | $3.7M Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 7,492 | $348.31 | $2.6M Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,721 | $348.01 | $598.9K Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,517 | $347.39 | $527.0K Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 2,841 | $346.16 | $983.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Xiaodong Wang Director | ONC BeOne Medicines Ltd. | Sale | 1,181 | $345.38 | $407.9K Sale | Form 4 ↗ |
| Sep 1, 2026 | Titus B. Ball Principal Accounting Officer | ONC BeOne Medicines Ltd. | Sale | 132 | $355.86 | $47.0K Sale | Form 4 ↗ |
| Aug 25, 2026 | Xiaobin Wu President and COO | ONC BeOne Medicines Ltd. | Sale | 280 | $380.00 | $106.4K Sale | Form 4 ↗ |
| Aug 12, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 14,102 | $359.12 | $5.1M Sale | Form 4 ↗ |
| Aug 12, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 20,899 | $358.41 | $7.5M Sale | Form 4 ↗ |
| Aug 12, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 15,396 | $357.63 | $5.5M Sale | Form 4 ↗ |
| Aug 12, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 2,515 | $356.43 | $896.4K Sale | Form 4 ↗ |
| Aug 12, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 1,980 | $354.71 | $702.3K Sale | Form 4 ↗ |
| Aug 11, 2026 | Chan Henry Lee SVP, General Counsel | ONC BeOne Medicines Ltd. | Sale | 2,666 | $360.00 | $959.8K Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 4 | $367.00 | $1,468 Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 1,200 | $366.31 | $439.6K Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 3,176 | $365.26 | $1.2M Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 5,211 | $364.31 | $1.9M Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 13,403 | $363.45 | $4.9M Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 11,568 | $362.34 | $4.2M Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 14,569 | $361.47 | $5.3M Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 8,081 | $360.33 | $2.9M Sale | Form 4 ↗ |
| Aug 11, 2026 | John Oyler Chief Executive Officer, Director | ONC BeOne Medicines Ltd. | Sale | 13,695 | $359.32 | $4.9M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances